vs
Side-by-side financial comparison of SCYNEXIS INC (SCYX) and Snail, Inc. (SNAL). Click either name above to swap in a different company.
Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $18.6M, roughly 1.3× SCYNEXIS INC). SCYNEXIS INC runs the higher net margin — 65.7% vs -3.4%, a 69.2% gap on every dollar of revenue. On growth, SCYNEXIS INC posted the faster year-over-year revenue change (1808.5% vs -4.2%). Over the past eight quarters, SCYNEXIS INC's revenue compounded faster (268.5% CAGR vs 33.4%).
SCYNEXIS Inc. is a biotechnology company focused on developing innovative antifungal therapies to address unmet medical needs for difficult-to-treat fungal infections. It targets hospital and specialty care markets, with key product candidates serving immunocompromised patients and other high-risk groups.
Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....
SCYX vs SNAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $25.1M |
| Net Profit | $12.3M | $-862.2K |
| Gross Margin | — | 38.3% |
| Operating Margin | 56.3% | -6.0% |
| Net Margin | 65.7% | -3.4% |
| Revenue YoY | 1808.5% | -4.2% |
| Net Profit YoY | 376.5% | -177.0% |
| EPS (diluted) | $0.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $25.1M | ||
| Q3 25 | $334.0K | $13.8M | ||
| Q2 25 | $1.4M | $22.2M | ||
| Q1 25 | $257.0K | $20.1M | ||
| Q4 24 | $977.0K | $26.2M | ||
| Q3 24 | $660.0K | $22.5M | ||
| Q2 24 | $736.0K | $21.6M | ||
| Q1 24 | $1.4M | $14.1M |
| Q4 25 | $12.3M | $-862.2K | ||
| Q3 25 | $-8.6M | $-7.9M | ||
| Q2 25 | $-6.9M | $-16.6M | ||
| Q1 25 | $-5.4M | $-1.9M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-2.8M | $235.1K | ||
| Q2 24 | $-14.5M | $2.3M | ||
| Q1 24 | $411.0K | $-1.8M |
| Q4 25 | — | 38.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 29.1% | ||
| Q4 24 | — | 43.3% | ||
| Q3 24 | — | 38.6% | ||
| Q2 24 | — | 37.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | 56.3% | -6.0% | ||
| Q3 25 | -2516.5% | -71.3% | ||
| Q2 25 | -701.0% | -8.2% | ||
| Q1 25 | -3350.2% | -20.4% | ||
| Q4 24 | — | 11.5% | ||
| Q3 24 | -1563.6% | 1.8% | ||
| Q2 24 | -1255.0% | 12.4% | ||
| Q1 24 | -692.5% | -15.6% |
| Q4 25 | 65.7% | -3.4% | ||
| Q3 25 | -2572.2% | -56.9% | ||
| Q2 25 | -504.8% | -74.7% | ||
| Q1 25 | -2097.7% | -9.7% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | -425.5% | 1.0% | ||
| Q2 24 | -1964.4% | 10.4% | ||
| Q1 24 | 29.9% | -12.6% |
| Q4 25 | $0.25 | — | ||
| Q3 25 | $-0.17 | — | ||
| Q2 25 | $-0.14 | $-0.44 | ||
| Q1 25 | $-0.11 | $-0.06 | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $-0.06 | $0.01 | ||
| Q2 24 | $-0.30 | $0.06 | ||
| Q1 24 | $0.01 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.0M | $8.6M |
| Total DebtLower is stronger | — | $14.6M |
| Stockholders' EquityBook value | $49.4M | $-16.4M |
| Total Assets | $59.0M | $59.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.0M | $8.6M | ||
| Q3 25 | $37.9M | $12.3M | ||
| Q2 25 | $44.8M | $7.9M | ||
| Q1 25 | $40.6M | $9.4M | ||
| Q4 24 | $59.3M | $7.3M | ||
| Q3 24 | $68.8M | $10.6M | ||
| Q2 24 | $73.0M | $15.5M | ||
| Q1 24 | $80.2M | $16.1M |
| Q4 25 | — | $14.6M | ||
| Q3 25 | — | $10.5M | ||
| Q2 25 | — | $11.8M | ||
| Q1 25 | — | $9.0M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $5.8M | ||
| Q1 24 | — | $6.5M |
| Q4 25 | $49.4M | $-16.4M | ||
| Q3 25 | $36.4M | $-15.6M | ||
| Q2 25 | $44.5M | $-8.0M | ||
| Q1 25 | $50.5M | $9.1M | ||
| Q4 24 | $55.1M | $9.7M | ||
| Q3 24 | $58.5M | $8.2M | ||
| Q2 24 | $60.4M | $7.9M | ||
| Q1 24 | $74.1M | $5.6M |
| Q4 25 | $59.0M | $59.3M | ||
| Q3 25 | $51.1M | $51.1M | ||
| Q2 25 | $60.7M | $58.0M | ||
| Q1 25 | $67.9M | $64.5M | ||
| Q4 24 | $90.6M | $62.2M | ||
| Q3 24 | $99.0M | $66.8M | ||
| Q2 24 | $107.8M | $75.4M | ||
| Q1 24 | $118.3M | $78.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 0.59× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | 0.73× | ||
| Q1 24 | — | 1.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.4M | $-5.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.4M | $-5.3M | ||
| Q3 25 | $-8.7M | $6.6M | ||
| Q2 25 | $-7.5M | $-3.2M | ||
| Q1 25 | $-7.5M | $764.5K | ||
| Q4 24 | $-24.0M | $-3.6M | ||
| Q3 24 | $765.0K | $-5.0M | ||
| Q2 24 | $-10.9M | $206.6K | ||
| Q1 24 | $-4.0M | $6.8M |
| Q4 25 | 1.50× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.21× | ||
| Q3 24 | — | -21.05× | ||
| Q2 24 | — | 0.09× | ||
| Q1 24 | -9.75× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SCYX
| Glaxosmithkline Intellectual Property | $17.2M | 92% |
| Products | $1.4M | 8% |
SNAL
| Pc | $14.7M | 59% |
| Platform Three | $5.2M | 21% |
| Platform Two | $3.3M | 13% |
| Sales Channel Directly To Consumer Mobile Sale | $1.6M | 6% |
